Worroll相关文献与解析，生知库 | 链接生命科学的每一步

Mijin Kim #, Chen Chen #, Zvi Yaari, Rune Frederiksen, Ewelina Randall, Jaina Wollowitz, Christian Cupo, Xiaojian Wu, Janki Shah, Daniel Worroll, Rachel E Lagenbacher, Dana Goerzen, Yue-Ming Li, Heeseon An, YuHuang Wang, Daniel A Heller

信号转导

细胞生物学

Autophagy

发表日期：2023

文献求助收藏

AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancer

AR-V7 在去势抵抗性前列腺癌中表现出非经典的核输入和染色质参与机制

期刊:Elife

影响因子:6.4

doi:10.7554/eLife.73396

Seaho Kim #, CheukMan C Au #, Mohd Azrin Bin Jamalruddin #, Naira Essam Abou-Ghali, Eiman Mukhtar, Luigi Portella, Adeline Berger, Daniel Worroll, Prerna Vatsa, David S Rickman, David M Nanus, Paraskevi Giannakakou

Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage

雄激素受体变体在前列腺癌中根据分化阶段表现出异质性表达

期刊:Communications Biology

影响因子:5.2

doi:10.1038/s42003-021-02321-9

Ada Gjyrezi, Giuseppe Galletti, Jiaren Zhang, Daniel Worroll, Michael Sigouros, Seaho Kim, Victoria Cooley, Karla V Ballman, Allyson J Ocean, Manish A Shah, Joseph M Scandura, Andrea Sboner, David M Nanus, Himisha Beltran, Scott Tagawa, Paraskevi Giannakakou

Quantitative analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRXL301, a nanoparticle of docetaxel

对接受 CRXL301（一种多西他赛纳米颗粒）治疗的转移性去势抵抗性前列腺癌患者循环肿瘤细胞中紫杉烷类药物靶点与微管的结合情况进行定量分析

期刊:Cancer Drug Resistance

影响因子:4.6

doi:10.20517/cdr.2019.116

Eiman Mukhtar ，Daniel Worroll ，Giuseppe Galletti ，Shelly Schuster ，Sarina A Piha-Paul ，Paraskevi Giannakakou

Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia

小分子靶向MUSASHI RNA结合活性治疗急性髓系白血病

期刊:Nature Communications

影响因子:14.7

doi:10.1038/s41467-019-10523-3

Gerard Minuesa ，Steven K Albanese ，Wei Xie ，Yaniv Kazansky ，Daniel Worroll ，Arthur Chow ，Alexandra Schurer ，Sun-Mi Park ，Christina Z Rotsides ，James Taggart ，Andrea Rizzi ，Levi N Naden ，Timothy Chou ，Saroj Gourkanti ，Daniel Cappel ，Maria C Passarelli ，Lauren Fairchild ，Carolina Adura ，J Fraser Glickman ，Jessica Schulman ，Christopher Famulare ，Minal Patel ，Joseph K Eibl ，Gregory M Ross ，Shibani Bhattacharya ，Derek S Tan ，Christina S Leslie ，Thijs Beuming ，Dinshaw J Patel ，Yehuda Goldgur ，John D Chodera ，Michael G Kharas

白血病

发表日期：2019

文献求助收藏

Expression of AR-V7 and ARv(567es) in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY

在TAXYNERGY研究中，循环肿瘤细胞中AR-V7和ARv(567es)的表达与转移性前列腺癌男性患者接受紫杉烷类药物治疗的疗效相关。

期刊:Clinical Cancer Research

影响因子:10.2

doi:10.1158/1078-0432.CCR-18-0320

Tagawa, Scott T; Antonarakis, Emmanuel S; Gjyrezi, Ada; Galletti, Giuseppe; Kim, Seaho; Worroll, Daniel; Stewart, John; Zaher, Atef; Szatrowski, Ted P; Ballman, Karla V; Kita, Katsuhiro; Tasaki, Shinsuke; Bai, Yang; Portella, Luigi; Kirby, Brian J; Saad, Fred; Eisenberger, Mario A; Nanus, David M; Giannakakou, Paraskevi

Androgen receptor nuclear localization correlates with AR-V7 mRNA expression in circulating tumor cells (CTCs) from metastatic castration resistance prostate cancer patients

转移性去势抵抗性前列腺癌患者循环肿瘤细胞 (CTC) 中的雄激素受体核定位与 AR-V7 mRNA 表达相关

期刊:Physical Biology

影响因子:2

doi:10.1088/1478-3975/ab073a

Daniel Worroll, Giuseppe Galletti, Ada Gjyrezi, David M Nanus, Scott T Tagawa, Paraskevi Giannakakou

Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer

一项随机、非对照、II期临床试验，旨在评估在未接受过化疗的转移性去势抵抗性前列腺癌患者中，早期从多西他赛转换为卡巴他赛或反之亦然的疗效，并结合生物标志物分析。

期刊:Journal of Clinical Oncology

影响因子:41.9

doi:10.1200/JCO.2017.72.4138

Antonarakis, Emmanuel S; Tagawa, Scott T; Galletti, Giuseppe; Worroll, Daniel; Ballman, Karla; Vanhuyse, Marie; Sonpavde, Guru; North, Scott; Albany, Costantine; Tsao, Che-Kai; Stewart, John; Zaher, Atef; Szatrowski, Ted; Zhou, Wei; Gjyrezi, Ada; Tasaki, Shinsuke; Portella, Luigi; Bai, Yang; Lannin, Timothy B; Suri, Shalu; Gruber, Conor N; Pratt, Erica D; Kirby, Brian J; Eisenberger, Mario A; Nanus, David M; Saad, Fred; Giannakakou, Paraskevi

Using circulating tumor cells to advance precision medicine in prostate cancer

利用循环肿瘤细胞推进前列腺癌精准医疗

期刊:Journal of Cancer Metastasis and Treatment

影响因子:1

doi:10.20517/2394-4722.2017.45

Galletti, Giuseppe; Worroll, Daniel; Nanus, David M; Giannakakou, Paraskevi

Nanosensor-based monitoring of autophagy-associated lysosomal acidification in vivo

基于纳米传感器的体内自噬相关溶酶体酸化监测

AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancer

AR-V7 在去势抵抗性前列腺癌中表现出非经典的核输入和染色质参与机制

Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage

雄激素受体变体在前列腺癌中根据分化阶段表现出异质性表达

Quantitative analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRXL301, a nanoparticle of docetaxel

对接受 CRXL301（一种多西他赛纳米颗粒）治疗的转移性去势抵抗性前列腺癌患者循环肿瘤细胞中紫杉烷类药物靶点与微管的结合情况进行定量分析

Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia

小分子靶向MUSASHI RNA结合活性治疗急性髓系白血病

Expression of AR-V7 and ARv(567es) in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY

在TAXYNERGY研究中，循环肿瘤细胞中AR-V7和ARv(567es)的表达与转移性前列腺癌男性患者接受紫杉烷类药物治疗的疗效相关。

Androgen receptor nuclear localization correlates with AR-V7 mRNA expression in circulating tumor cells (CTCs) from metastatic castration resistance prostate cancer patients

转移性去势抵抗性前列腺癌患者循环肿瘤细胞 (CTC) 中的雄激素受体核定位与 AR-V7 mRNA 表达相关

Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer

一项随机、非对照、II期临床试验，旨在评估在未接受过化疗的转移性去势抵抗性前列腺癌患者中，早期从多西他赛转换为卡巴他赛或反之亦然的疗效，并结合生物标志物分析。

Using circulating tumor cells to advance precision medicine in prostate cancer

利用循环肿瘤细胞推进前列腺癌精准医疗